After 50 Years, U.S. Opens The Door To More Cannabis Crops For Scientists
After more than 50 years, the federal government is lifting a roadblock to cannabis research that scientists and advocates say has hindered rigorous studies of the plant and possible drug development.
Since 1968, U.S. researchers have been allowed to use cannabis from only one domestic source: a facility based at the University of Mississippi, through a contract with the National Institute on Drug Abuse (NIDA).
That changed earlier this month, when the Drug Enforcement Administration announced it’s in the process of registering several additional American companies to produce cannabis for medical and scientific purposes.
Stories you may be interested in
Minnesota study finds that medical pot soothes cancer pains
Symptoms such as pain and nausea improved in cancer patients who took cannabis, according to new research that is part of Minnesota’s effort to address the information void about whether marijuana offers medical benefits. Analyzing 1,120 cancer patients who received cannabis through the state medical marijuana program, researchers reported Monday that they found noteworthy improvements…
Read More 
After marijuana edibles helped dying Holocaust survivor battle Alzheimer’s, his family’s foundation pushes for more research
A Massachusetts family’s experience giving marijuana edibles to their dying patriarch is set to kick off a desperately needed investigation into how cannabis might treat some of the more troubling symptoms of Alzheimer’s disease, a condition that affects 5.7 million Americans. Read the full story here.
Read More 
Colorado’s first licensed cannabis R&D firm to study marijuana’s effect on Alzheimer’s disease
A Denver-based company hopes to be the state’s first to study the effects of marijuana on Alzheimer’s disease, thanks to a newly available research and development license in the city. MedPharm Holdings plans to apply for a Denver marijuana R&D license to test delta-9 tetrahydrocannabinol (THC), cannabidiol (CBD) and other cannabinoids’ effects on Alzheimer’s and…
Read More 
Dr. Sanjay Gupta on medical marijuana: We are in an age of wisdom, but also an age of foolishness
When we released “Weed” in 2013, few people had ever heard of cannabidiol, or CBD. Now, two-thirds of Americans are familiar with the compound, and 1 in 7 have tried it. Most of the country, 93%, are in favor of medical marijuana and hemp-derived CBD itself, which has less than 0.3% THC, has been legalized in every state.It’s…
Read More 
Older adults and medical marijuana: Reduced stigma and increased use
As a primary care doctor who has incorporated medical cannabis into his practice, it is notable how many silver-haired patients are coming in to discuss the pros and cons of a trial of medical cannabis. These patients range from people in their 60s with kidney failure who can no longer take certain pain medications but…
Read More 
Scientists Discover Two New Cannabinoids
The plant Cannabis sativa produces more than 400 chemicals, but only one, THC, gets you high. Or so it seems. A group of Italian researchers announced on December 30th the discovery of two new cannabinoids, chemicals produced by weed like THC and CBD. The first, tetrahydrocannabiphorol (THCP), is allegedly 30 times more potent than THC, they claim.…
Read More